We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+13.38%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$106M
(-9.2%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-16.63%
Top 10 Holdings %
Top 10 Hldgs %
5.73%
Holding
1,387
New
364
Increased
246
Reduced
349
Closed
422
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$5.05M |
| 2 |
Century Aluminum
CENX
|
+$4.6M |
| 3 |
CBM
Cambrex Corporation
CBM
|
+$4.54M |
| 4 |
BBBY
Bed Bath & Beyond
BBBY
|
+$4.51M |
| 5 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$4.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OneSpan
OSPN
|
+$7.67M |
| 2 |
Lattice Semiconductor
LSCC
|
+$7.09M |
| 3 |
Mercury Insurance
MCY
|
+$5.38M |
| 4 |
Omnicell
OMCL
|
+$5.15M |
| 5 |
Maximus
MMS
|
+$4.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.11% |
| 2 | Technology | 14.11% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 10.88% |
| 5 | Financials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GHI
701
DELISTED
GLOBAL HIGH INCOME FUND INC.
GHI
| $333K | 0.03% |
+37,749
| New | +$352K |
|
|
RAD
702
DELISTED
Rite Aid Corporation
RAD
| $331K | 0.03% |
2,199
-2,964
| -57% | -$329K |
|
|
EPE
703
DELISTED
EP Energy Corporation
EPE
| $330K | 0.03% |
+31,600
| New | +$405K |
|
704
Barings BDC
BBDC
$868M
| $328K | 0.03% |
16,157
+5,269
| +48% | +$119K |
|
705
KRONOS Worldwide
KRO
$705M
| $327K | 0.03% |
+25,089
| New | +$326K |
|
|
NSR
706
DELISTED
Neustar Inc
NSR
| $326K | 0.03% |
+11,722
| New | +$308K |
|
|
GTT
707
DELISTED
GTT Communications, Inc.
GTT
| $325K | 0.03% |
24,529
+2,276
| +10% | +$29.2K |
|
708
Sonida Senior Living
SNDA
$2.03B
| $323K | 0.03% |
865
+147
| +20% | +$51.9K |
|
|
BFX
709
DELISTED
BowFlex Inc.
BFX
| $320K | 0.03% |
21,067
-29,517
| -58% | -$394K |
|
710
MillerKnoll
MLKN
$1.54B
| $319K | 0.03% |
10,823
-11,329
| -51% | -$345K |
|
711
Tetra Tech
TTEK
$8.28B
| $319K | 0.03% |
59,750
-2,240
| -4% | -$11.7K |
|
|
CBF
712
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
| $318K | 0.03% |
+11,857
| New | +$300K |
|
|
ATRS
713
DELISTED
Antares Pharma, Inc.
ATRS
| $317K | 0.03% |
123,418
-39,989
| -24% | -$89.8K |
|
|
ECYT
714
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $317K | 0.03% |
50,403
+33,960
| +207% | +$207K |
|
|
TIVO
715
DELISTED
TIVO INC
TIVO
| $317K | 0.03% |
26,786
+3,481
| +15% | +$43.5K |
|
|
LMNX
716
DELISTED
Luminex Corp
LMNX
| $314K | 0.03% |
16,712
-140,691
| -89% | -$2.67M |
|
|
DALN
717
DELISTED
DallasNews
DALN
| $311K | 0.03% |
7,493
+1,260
| +20% | +$58.5K |
|
|
AGEN
718
Agenus
AGEN
$255M
| $308K | 0.03% |
3,958
-21,065
| -84% | -$1.3M |
|
|
CCRN
719
DELISTED
Cross Country Healthcare
CCRN
| $307K | 0.03% |
24,628
-83,309
| -77% | -$851K |
|
|
DEX
720
DELISTED
DELAWARE ENHANCED GLOBAL DIVIDEND & INCOME FUND
DEX
| $306K | 0.03% |
+27,154
| New | +$316K |
|
|
THR
721
DELISTED
Thermon Group Holdings
THR
| $305K | 0.03% |
+12,625
| New | +$300K |
|
|
SIMG
722
DELISTED
SILICON IMAGE INC
SIMG
| $304K | 0.03% |
55,147
-881,400
| -94% | -$4.74M |
|
|
AWF
723
AllianceBernstein Global High Income Fund
AWF
$868M
| $299K | 0.03% |
+24,036
| New | +$317K |
|
|
CVO
724
DELISTED
Cenevo, Inc.
CVO
| $299K | 0.03% |
+17,799
| New | +$296K |
|
725
Bankunited
BKU
$3.36B
| $296K | 0.03% |
+10,226
| New | +$302K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q4 2014 Portfolio in Review
As of Q4 2014, TFS Capital held 1,387 positions worth $1.05B, down 9.2% from $1.15B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
TFS Capital withdrew a net $174M in Q4 2014, closing 422 positions and reducing 349 holdings. Its most notable exit was Lattice Semiconductor, an estimated $7.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, TFS Capital opened a new position in Infinity Pharmaceuticals, Inc. worth $5.86M.
- TFS Capital's largest Q4 2014 buy was Infinity Pharmaceuticals, Inc.: 347,088 shares worth $5.86M.
- TFS Capital added most to Cambrex Corporation in Q4 2014, an estimated $4.54M increase.
- TFS Capital's biggest Q4 2014 reduction was OneSpan, cutting an estimated $7.67M.
- TFS Capital fully exited Lattice Semiconductor in Q4 2014, selling an estimated $7.09M.
- TFS Capital's ten largest holdings make up 5.7% of its $1.05B portfolio in Q4 2014.
- TFS Capital opened 364 new positions and closed 422 in Q4 2014.
- TFS Capital's portfolio value fell 9.2% quarter-over-quarter to $1.05B.
Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.